Co-development of innovative new drug for the treatment of Fabry disease as “the world’s first once-monthly subcutaneous treatment” Improves efficacy compared to existing treatment for kidney function, vascular disease, and peripheral nerve disorders YONGIN, South Korea, Sept. 3, 2024…
Month: September 2024
Co-development of innovative new drug for the treatment of Fabry disease as “the world’s first once-monthly subcutaneous treatment” Improves efficacy compared to existing treatment for kidney function, vascular disease, and peripheral nerve disorders YONGIN, South Korea, Sept. 3, 2024…
WALLDORF, Germany, Sept. 3, 2024 /PRNewswire/ — SAP SE (NYSE: SAP) today announced that the SAP Supervisory Board has reached a mutual agreement with Chief Technology Officer and Executive Board Member Dr.-Ing. Jürgen Müller to leave the company’s Executive Board, effective September 30,…
WALLDORF, Germany, Sept. 3, 2024 /PRNewswire/ — SAP SE (NYSE: SAP) today announced that the SAP Supervisory Board has reached a mutual agreement with Chief Technology Officer and Executive Board Member Dr.-Ing. Jürgen Müller to leave the company’s Executive Board, effective September 30,…
UPPSALA, Sweden, Sept. 3, 2024 /PRNewswire/ — Orexo AB (Publ.), (STO: ORX) (OTCQX: ORXOY), today announces the company will participate in Pareto Securities’ 15th Annual Healthcare Conference, that takes place on September 19, at Downtown Camper by Scandic, Brunkebergstorg 9, Stockholm,…
UPPSALA, Sweden, Sept. 3, 2024 /PRNewswire/ — Orexo AB (Publ.), (STO: ORX) (OTCQX: ORXOY), today announces the company will participate in Pareto Securities’ 15th Annual Healthcare Conference, that takes place on September 19, at Downtown Camper by Scandic, Brunkebergstorg 9, Stockholm,…
BEIJING, Sept. 3, 2024 /PRNewswire/ — Hello Group Inc. (NASDAQ: MOMO) (“Hello Group” or the “Company”), a leading player in mainland China’s online social networking space, today announced its unaudited financial results for the second quarter of 2024. Second Quarter of 2024 Highlights…
BEIJING, Sept. 3, 2024 /PRNewswire/ — Hello Group Inc. (NASDAQ: MOMO) (“Hello Group” or the “Company”), a leading player in mainland China’s online social networking space, today announced its unaudited financial results for the second quarter of 2024. Second Quarter of 2024 Highlights…
– Abstract on data from a two-part phase 1c, multiple ascending dose study accepted for oral presentation – – New data highlighting the Company’s lead drug candidate ZT002 for obesity – BEIJING, Sept. 3, 2024 /PRNewswire/ — Beijing QL Biopharmaceutical Co., Ltd. (“QL Biopharm”), a…
– Abstract on data from a two-part phase 1c, multiple ascending dose study accepted for oral presentation – – New data highlighting the Company’s lead drug candidate ZT002 for obesity – BEIJING, Sept. 3, 2024 /PRNewswire/ — Beijing QL Biopharmaceutical Co., Ltd. (“QL Biopharm”), a…